---
slug: nad-plus
title: "nad plus"
kind: standard
status: published
hash: d6d358efb60aa16c55bb9d251d0d3fbb2caef317bbf6e463578d96c02a615061
created: 2026-06-29T17:09:32.135Z
updated: 2026-10-08T11:49:39.101Z
summary: "Evidence is being populated by Grok web"
tags: []
above: []
below: []
adjacent: []
nested: []
---
# nad plus

*Evidence is being populated by Grok web*

## Overview
Evidence is being populated by Grok web search.

## Facts

```json
{
  "converted_from": "markdown",
  "original_updated": "2026-06-29T17:09:55.259Z",
  "register": "standard",
  "category": null
}
```

## Sources

1. [Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review](https://pubmed.ncbi.nlm.nih.gov/37971292/) — “This review includes 10 studies, with a total of 489 participants. ... NADH supplementation is safe and has a low incidence of side effects. Future investigations are needed to evidence the clinical benefits regarding specific diseases and doses administered.” (sha256 b907b031b16fd066)
2. [NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence](https://pubmed.ncbi.nlm.nih.gov/41655607/) — “We identified 113 eligible studies: 33 human intervention studies (28 randomized; 5 nonrandomized) and 80 rodent studies. ... Overall, NAD⁺ augmentation shows clear biological activity, but clinical effectiveness for anti-aging or wellness outcomes remains inconclusive.” (sha256 a2d6ee417b86672e)
3. [Effects of NAD+ supplementation with oral nicotinamide riboside on vascular health and cognitive function in older adults with peripheral artery disease: Results from a pilot 4-week open-label clinical trial](https://pubmed.ncbi.nlm.nih.gov/40479886/) — “Preliminary results indicate a positive trend in peripheral endothelial function, significant improvements in cerebrovascular response in the left dorsolateral prefrontal cortex, and cognitive enhancement across multiple domains postsupplementation. ... These findings suggest that NR supplementation could ameliorate cognitive outcomes in older adults with PAD.” (sha256 7452d8efce75f2d8)
4. [Effect of Nicotinamide Adenine Dinucleotide on Heart Failure Caused by Ischemic Cardiomyopathy: A Randomized, Placebo-Controlled Trial](https://pubmed.ncbi.nlm.nih.gov/40954388/) — “This study has confirmed that supplementation with NAD+ can enhance cardiac function in patients with from HF due to ICM, thereby affirming its beneficial impact on cardiac performance.” (sha256 3acccd83f9584c2e)
5. [The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans](https://pubmed.ncbi.nlm.nih.gov/41540253/) — “Here we show in a randomized, open-label, placebo-controlled study in 65 healthy participants that 14 days of supplementation with NR and NMN, but not Nam, comparably increases circulatory NAD + concentrations in healthy adults.” (sha256 692b9eccd6eaa57d)
6. [NAD+ precursor supplementation in human ageing: clinical evidence and challenges](https://pubmed.ncbi.nlm.nih.gov/41083806/) — “In this Review, we evaluate the clinical evidence supporting the notion that NAD + levels decline with age, as well as the tissue-specific effects of NAD + precursor supplementation in humans.” (sha256 fa7656d6b7595f2c)
7. [Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting](https://pubmed.ncbi.nlm.nih.gov/41704678/) — “Supplementation with NAD + and its precursors is commonly used to prevent age-related disease and extend healthspan.” (sha256 0a8306a700dc02bb)